Cargando…
Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives
ABSTRACT: This article describes the synthesis and antimicrobial activity evaluation of new pipemidic acid derivatives. New compounds were obtained on the basis of Mannich reaction of 4,5-disubstituted 1,2,4-triazole-3-thiones with pipemidic acid. Antimicrobial tests revealed high antibacterial acti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pharmaceutical Society of Korea
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028826/ https://www.ncbi.nlm.nih.gov/pubmed/29619676 http://dx.doi.org/10.1007/s12272-018-1025-3 |
_version_ | 1783336847574827008 |
---|---|
author | Popiołek, Łukasz Biernasiuk, Anna Paruch, Kinga Malm, Anna Wujec, Monika |
author_facet | Popiołek, Łukasz Biernasiuk, Anna Paruch, Kinga Malm, Anna Wujec, Monika |
author_sort | Popiołek, Łukasz |
collection | PubMed |
description | ABSTRACT: This article describes the synthesis and antimicrobial activity evaluation of new pipemidic acid derivatives. New compounds were obtained on the basis of Mannich reaction of 4,5-disubstituted 1,2,4-triazole-3-thiones with pipemidic acid. Antimicrobial tests revealed high antibacterial activity of obtained derivatives. Gram-negative rods belonging to Enterobacteriaceae family were particularly most sensitive to new pipemidic acid derivatives. Synthesized compounds exhibited very strong activity towards Proteus mirabilis ATCC 12453, Salmonella typhimurium ATCC 14028 and Escherichia coli ATCC 25922. The minimum inhibitory concentrations of new pipemidic acid derivatives which inhibited the growth of these bacteria were 0.98–7.81 µg/ml, 0.98–7.81 µg/ml and 0.98–3.91 µg/ml, respectively. The antibacterial activity of newly synthesized pipemidic acid derivatives in many cases was far better than the activity of substances used as positive controls (nitrofurantoin, cefuroxime, ampicillin and pipemidic acid). GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12272-018-1025-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6028826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Pharmaceutical Society of Korea |
record_format | MEDLINE/PubMed |
spelling | pubmed-60288262018-07-23 Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives Popiołek, Łukasz Biernasiuk, Anna Paruch, Kinga Malm, Anna Wujec, Monika Arch Pharm Res Research Article ABSTRACT: This article describes the synthesis and antimicrobial activity evaluation of new pipemidic acid derivatives. New compounds were obtained on the basis of Mannich reaction of 4,5-disubstituted 1,2,4-triazole-3-thiones with pipemidic acid. Antimicrobial tests revealed high antibacterial activity of obtained derivatives. Gram-negative rods belonging to Enterobacteriaceae family were particularly most sensitive to new pipemidic acid derivatives. Synthesized compounds exhibited very strong activity towards Proteus mirabilis ATCC 12453, Salmonella typhimurium ATCC 14028 and Escherichia coli ATCC 25922. The minimum inhibitory concentrations of new pipemidic acid derivatives which inhibited the growth of these bacteria were 0.98–7.81 µg/ml, 0.98–7.81 µg/ml and 0.98–3.91 µg/ml, respectively. The antibacterial activity of newly synthesized pipemidic acid derivatives in many cases was far better than the activity of substances used as positive controls (nitrofurantoin, cefuroxime, ampicillin and pipemidic acid). GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12272-018-1025-3) contains supplementary material, which is available to authorized users. Pharmaceutical Society of Korea 2018-04-04 2018 /pmc/articles/PMC6028826/ /pubmed/29619676 http://dx.doi.org/10.1007/s12272-018-1025-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Article Popiołek, Łukasz Biernasiuk, Anna Paruch, Kinga Malm, Anna Wujec, Monika Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives |
title | Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives |
title_full | Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives |
title_fullStr | Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives |
title_full_unstemmed | Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives |
title_short | Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives |
title_sort | synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028826/ https://www.ncbi.nlm.nih.gov/pubmed/29619676 http://dx.doi.org/10.1007/s12272-018-1025-3 |
work_keys_str_mv | AT popiołekłukasz synthesisandinvitroantimicrobialactivityscreeningofnewpipemidicacidderivatives AT biernasiukanna synthesisandinvitroantimicrobialactivityscreeningofnewpipemidicacidderivatives AT paruchkinga synthesisandinvitroantimicrobialactivityscreeningofnewpipemidicacidderivatives AT malmanna synthesisandinvitroantimicrobialactivityscreeningofnewpipemidicacidderivatives AT wujecmonika synthesisandinvitroantimicrobialactivityscreeningofnewpipemidicacidderivatives |